Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Yazar: | Siddika, Khadiza |
---|---|
Diğer Yazarlar: | Ahmed, Syeda Maliha |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
Brac University
2024
|
Konular: | |
Online Erişim: | http://hdl.handle.net/10361/24296 |
Benzer Materyaller
-
Targeted therapeutic options in the treatment of Breast Cancer
Yazar:: Alam, Kazi Tasnuva
Baskı/Yayın Bilgisi: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
Yazar:: Rattry, Faria Rahman
Baskı/Yayın Bilgisi: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Yazar:: Tania, Umme
Baskı/Yayın Bilgisi: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
Yazar:: Jahan, Nusrat
Baskı/Yayın Bilgisi: (2024) -
Molecular biology : genes to proteins /
Yazar:: Tropp, Burton E.
Baskı/Yayın Bilgisi: (2008)